PwC receives "high marks for underpromising and overdelivering"
Speaking to PwC’s history in the space, the IDC report notes, “PwC is among the main service providers of R&D strategic consulting and carries a legacy of strong strategic consulting services to the industry. The company has a broad customer base, a strong global footprint, and significant success in engaging and expanding its relationship with top-tier pharmaceutical companies.” The report continues, “PwC has extensive experience working with life science companies across all three sections of the industry: pharmaceutical, biotech, and medical devices.”
On PwC’s current standing in the industry, the IDC report states, “More than 70% of PwC's life science customers are large corporations with revenue over $1 billion, with a significant base of customers spread across North America, Europe, and Asia/Pacific.”
IDC expands on client feedback on PwC’s services, “Relative to other vendors discussed in this report and based on feedback from multiple customer references, PwC continues to receive high marks for underpromising and overdelivering; bringing deep, industry-specific knowledge to engagements; and uniquely understanding industry needs from a business perspective.”
Kelly Barnes, Global & US Health Industries Leader at PwC, said of the leadership position, “We are proud to be named a leader for our work in Worldwide Life Science R&D Strategic Consulting. We help our clients meet the constantly evolving and increasingly demanding challenges in the health industry to formulate new strategies for success.”
Anup Kharode, Pharmaceutical and Life Sciences R&D Practice Leader at PwC, added, “Biopharma R&D organizations are enabling the groundbreaking science and development that is paving the path to treat patients. We value the work we are doing with our clients everyday to advance these innovations."
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. The Capabilities score measures vendor product, go-to-market and business execution in the shortterm. The Strategy score measures alignment of vendor strategies with customer requirements in a 3-5-year timeframe. Vendor market share is represented by the size of the circles. Vendor year-over-year growth rate relative to the given market is indicated by a plus, neutral or minus next to the vendor name.
- To find out more about PwC’s life science offerings, visit https://www.pwc.com/gx/en/industries/pharmaceuticals-life-sciences.html
- To find out more about how PwC has been evaluated by leading business, technology and industry analysts visit pwc.com/analystviews
- At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 158 countries with more than 236,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com
PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure
for further details.
©2018 PwC. All rights reserved.